Assura PLC

Remuneration Information • Sep 1, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5819P

Assura PLC

01 September 2017

1 September 2017

Assura plc

Exercise of Nil Cost Options under VCP

Assura plc ("Assura"), the leading primary care property investor and developer announces that on 31 August 2017, all PDMRs and staff exercised the third and final element of their awards (25% by number) of the Assura Group Value Creation Plan ("VCP") which were exercisable under the Rules of the VCP.

The table below shows the number of nil cost options exercised by PDMRs, the number of shares sold to satisfy Income Tax and National Insurance liabilities and the number of shares they will receive following the sale to satisfy Income Tax and national insurance liabilities.

	Number of Nil Cost Options exercised	Number of shares sold to satisfy Income Tax and National Insurance liabilities	Additional shares sold	Number of shares after shares sold
Jonathan Murphy (CEO)	1,288,355	(605,527)	nil	682,828
Andrew Darke (Property Director)	1,472,406	(692,031)	(439,490)	340,885

The Remuneration Committee of Assura had previously agreed that sufficient shares may be sold by PDMRs to cover the arising Income Tax and National Insurance liabilities. The relevant market price for taxation purposes is 65.35 pence per share being the mid-market price at close of business on 30 August 2017.

As a result of the above, the increases in the shareholdings of the PDMRs are as follows:

	Shareholding on 29 August 2017	Shareholding  post exercise
Jonathan Murphy (CEO)	1,640,346	2,323,174
Andrew Darke (Property Director)	1,159,115	1,500,000

The Notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jonathan Murphy

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Assura plc

b)

LEI

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Vesting of share awards under VCP

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£NIL GBP	1,288,355

d)

Aggregated information

-     Aggregated volume

-    Price

N/A

e)

Date of the transaction

31 August 2017

f)

Place of the transaction

XLON

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Sale of 605,527 shares to satisfy tax and national insurance liabilities.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£0.65057 GBP	605,527

d)

Aggregated information

-     Aggregated volume

-    Price

N/A

e)

Date of the transaction

31 August 2017

f)

Place of the transaction

XLON

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Andrew Darke

2

Reason for the notification

a)

Position/status

Property Director

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Assura plc

b)

LEI

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Vesting of share awards under VCP

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£NIL GBP	1,472,406

d)

Aggregated information

-     Aggregated volume

-    Price

N/A

e)

Date of the transaction

31 August 2017

f)

Place of the transaction

XLON

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Sale of 1,131,521 shares, 692,031 of which are sold to satisfy tax and national insurance liabilities.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£0.65057 GBP	1,131,521

d)

Aggregated information

-     Aggregated volume

-    Price

N/A

e)

Date of the transaction

31 August 2017

f)

Place of the transaction

XLON

- Ends -

For more information, please contact:

Assura plc	Tel: 01925 420660
Orla Ball
Finsbury	Tel: 0207 251 3801
Gordon Simpson

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2017, Assura's property portfolio was valued at £1,345 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCUGURPBUPMUBG